{"id":1068525,"date":"2024-06-03T02:37:21","date_gmt":"2024-06-03T06:37:21","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/vidac-pharma-receives-us-patent-office-notice-of-allowance-for-crucial-compounds-in-its-cancer-drug-candidates\/"},"modified":"2024-08-18T11:48:23","modified_gmt":"2024-08-18T15:48:23","slug":"vidac-pharma-receives-us-patent-office-notice-of-allowance-for-crucial-compounds-in-its-cancer-drug-candidates","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/vidac-pharma-receives-us-patent-office-notice-of-allowance-for-crucial-compounds-in-its-cancer-drug-candidates.php","title":{"rendered":"Vidac Pharma receives US patent office Notice of Allowance for crucial compounds in its cancer drug candidates"},"content":{"rendered":"<p><![CDATA[London (UK), June 3, 2024 (07:30 CET) \u2013\u00a0Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage oncology biopharmaceutical company pioneering a novel class of cancer treatments, today announces it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) protecting a group of molecules and their ability to trigger an immune response across a wide range of cancers by detaching the Hexokinase-2 (HK2) enzyme from the mitochondrial VDAC pores. The molecules are the crucial compounds in Vidac\u2019s two drug candidates, VDA-1102 and VDA-1275.]]><\/p>\n<p>See the original post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/06\/03\/2891897\/0\/en\/Vidac-Pharma-receives-US-patent-office-Notice-of-Allowance-for-crucial-compounds-in-its-cancer-drug-candidates.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Vidac Pharma receives US patent office Notice of Allowance for crucial compounds in its cancer drug candidates\">Vidac Pharma receives US patent office Notice of Allowance for crucial compounds in its cancer drug candidates<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the original post: Vidac Pharma receives US patent office Notice of Allowance for crucial compounds in its cancer drug candidates <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/vidac-pharma-receives-us-patent-office-notice-of-allowance-for-crucial-compounds-in-its-cancer-drug-candidates.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068525","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068525"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068525"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068525\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068525"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068525"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068525"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}